APOE*3-Leiden.CETP mice were also employed to demonstrate the efficacy of anti-PCSK9 therapies for lowering LDL-C and TGs, which translated to reduced atherosclerosis development in the aortic root [53]. The gene discussed is CETP; the disease is atherosclerosis.